BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14645945)

  • 1. Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s.
    Carter SM; Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii23-30. PubMed ID: 14645945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
    Cummings KM; Morley CP; Hyland A
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation and control: the Tobacco Institute of Australia.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii54-60. PubMed ID: 14645949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From legitimate consumers to public relations pawns: the tobacco industry and young Australians.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii71-8. PubMed ID: 14645951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "A deep fragrance of academia": the Australian Tobacco Research Foundation.
    Chapman S; Carter SM; Peters M
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii38-44. PubMed ID: 14645947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Conclusions about exposure to ETS and health that will be unhelpful to us": how the tobacco industry attempted to delay and discredit the 1997 Australian National Health and Medical Research Council report on passive smoking.
    Trotter L; Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii102-6. PubMed ID: 14645955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.
    Elias J; Hendlin YH; Ling PM
    PLoS Med; 2018 May; 15(5):e1002562. PubMed ID: 29715300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Can't stop the boy": Philip Morris' use of Healthy Buildings International to prevent workplace smoking bans in Australia.
    Chapman S; Penman A
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii107-12. PubMed ID: 14645956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Some convincing arguments to pass back to nervous customers": the role of the tobacco retailer in the Australian tobacco industry's smoker reassurance campaign 1950-1978.
    Tofler A; Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii7-12. PubMed ID: 14645943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'We will speak as the smoker': the tobacco industry's smokers' rights groups.
    Smith EA; Malone RE
    Eur J Public Health; 2007 Jun; 17(3):306-13. PubMed ID: 17065174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The whole truth and nothing but the truth? The research that Philip Morris did not want you to see.
    Diethelm PA; Rielle JC; McKee M
    Lancet; 2005 Jul 2-8; 366(9479):86-92. PubMed ID: 15993237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.
    Lopipero P; Bero LA
    Tob Control; 2006 Aug; 15(4):323-32. PubMed ID: 16885582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health.
    Muggli ME; Hurt RD
    Tob Control; 2003 Jun; 12(2):195-202. PubMed ID: 12773731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'It's interesting how few people die from smoking': tobacco industry efforts to minimize risk and discredit health promotion.
    Smith EA
    Eur J Public Health; 2007 Apr; 17(2):162-70. PubMed ID: 16837518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
    Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big tobacco "pull out all stops" for a landmark example: The Burswood Casino case.
    Laura B; Julia S; Mike D
    Australas Med J; 2011; 4(12):645-54. PubMed ID: 22905040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.
    Pauly JL; Mepani AB; Lesses JD; Cummings KM; Streck RJ
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I51-61. PubMed ID: 11893815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.